Precision Therapeutics receives $1,370,000 investment from CEO Carl Schwartz
Precision Therapeutics announced that its CEO and director, Carl Schwartz, has made an additional investment of $1,000,000 in the Company. Of this investment, $950,000 was a loan under an amended and restated promissory note. January 18, 2019